What questions should I ask my oncologist about locally advanced Head and Neck Cancer
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Key Questions to Ask Your Oncologist About Locally Advanced Head and Neck Cancer
Based on current treatment guidelines, here are the most important questions to help you understand your specific situation and treatment options:
ABOUT YOUR DIAGNOSIS & STAGING
-
"Can you explain my specific stage and what 'locally advanced' means for my particular cancer location?"
- This helps you understand whether your cancer is in the larynx, oropharynx, hypopharynx, or another head and neck site—each has different treatment approaches according to NCCN Guidelines.
-
"What testing have you done or will you do to determine my treatment options?"
- Ask specifically about: HPV/p16 testing (especially important for oropharyngeal cancer), PD-L1 testing, imaging (CT/MRI), and any other biomarker testing. These results directly influence which treatments are recommended.
-
"What are my risk factors, and do I have any 'adverse pathologic features'?"
- Understanding factors like extranodal extension, positive margins, or perineural invasion helps explain why your doctor recommends specific treatments.
ABOUT TREATMENT OPTIONS
-
"What are ALL my treatment options for my specific stage and location?"
- According to NCCN Guidelines, locally advanced head and neck cancer typically involves combinations of: surgery, radiation therapy, chemotherapy, and/or immunotherapy. Ask which apply to you and why.
-
"Am I a candidate for larynx-preserving (conservation) surgery, or will I need more extensive surgery?"
- This is a critical quality-of-life question. Some patients can avoid total laryngectomy (removal of the voice box) depending on tumor location and size.
-
"If you recommend concurrent chemotherapy and radiation, what chemotherapy agent would you use, and why?"
- NCCN Guidelines indicate cisplatin is the preferred agent when combined with radiation. Ask about the specific dose, schedule, and expected side effects.
-
"What role might immunotherapy (like pembrolizumab) play in my treatment plan?"
- NCCN Guidelines now include neoadjuvant pembrolizumab (before other treatment) for certain patients with PD-L1 positive tumors. Ask if this applies to you.
ABOUT SIDE EFFECTS & QUALITY OF LIFE
-
"What are the most common and serious side effects I should expect, and how will we manage them?"
- Head and neck cancer treatment can affect swallowing, speech, taste, and breathing. Understanding these helps you prepare.
-
"Will I need a feeding tube, and if so, for how long?"
- This is a practical question many patients need answered upfront.
-
"What supportive care will I receive during treatment?"
- Ask about: nutrition support, speech and swallowing therapy, dental evaluation, and mental health screening. NCCN Guidelines recommend these as standard care.
-
"Should I see a speech-language pathologist or swallowing specialist before treatment starts?"
- Early evaluation helps establish baseline function and plan rehabilitation.
ABOUT YOUR SPECIFIC SITUATION
-
"Do I need induction chemotherapy (chemotherapy before radiation/surgery), or should we proceed directly to concurrent treatment?"
- This depends on your specific tumor characteristics and overall health.
-
"What is your experience treating head and neck cancer at my specific stage and location?"
- This is a fair question about your oncologist's expertise and outcomes.
-
"If I'm a smoker, what smoking cessation support do you recommend?"
- NCCN Guidelines emphasize that all current smokers should be advised to quit, as smoking affects treatment outcomes and increases risk of second cancers.
ABOUT FOLLOW-UP & MONITORING
-
"What will follow-up look like after treatment ends, and how often will I be monitored?"
- Ask about imaging schedules, physical exams, and what symptoms should prompt urgent evaluation.
-
"What is the plan if my cancer doesn't respond to treatment or comes back?"
- Understanding salvage options (reirradiation, surgery, clinical trials) helps you feel prepared.
ABOUT CLINICAL TRIALS
- "Are there clinical trials available for my specific situation?"
- NCCN Guidelines frequently recommend considering clinical trials as an option, especially for advanced disease.
PRACTICAL QUESTIONS
-
"What should I do to prepare for treatment (nutrition, dental work, etc.)?"
-
"Who is on my treatment team, and how do I reach them with questions?"
- Head and neck cancer treatment requires a multidisciplinary team (surgeon, radiation oncologist, medical oncologist, speech pathologist, nutritionist, dentist).
-
"Can you provide written summaries of my treatment plan and pathology results?"
- Having documentation helps you stay organized and share information with other providers if needed.
WHY THESE QUESTIONS MATTER
According to NCCN Head and Neck Cancer Guidelines, treatment decisions for locally advanced disease depend on:
- Tumor location and size (different sites have different approaches)
- Nodal involvement (whether cancer has spread to lymph nodes)
- HPV/p16 status (especially for oropharyngeal cancer—HPV-positive tumors often respond better to treatment)
- PD-L1 expression (determines if immunotherapy is an option)
- Your overall health and ability to tolerate treatment
- Your priorities (voice preservation, swallowing function, etc.)
BEFORE YOUR APPOINTMENT
Consider:
- Writing down your questions in advance
- Bringing a trusted family member or friend to take notes
- Asking for copies of your pathology report and imaging results
- Requesting a second opinion if you feel uncertain
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Head and Neck Cancers (2026)Browse all NCCN Guidelines for Patients →Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: